Newborn Screening for Metabolic and Sickle Cell Disorders Program
The Georgia Newborn Screening Program endeavors to ensure that all newborns diagnosed with metabolic, endocrine, hemoglobin or cystic fibrosis abnormality is entered into and maintained on appropriate medical therapy. In order to do this, additional testing is commonly performed after a baby has an abnormal newborn screen. Healthcare providers can contact one of the follow-up programs for recommendations in regards to the additional testing needed.
This section provides information on the disorders detected via newborn screening, including:
All disorders on the Georgia newborn screening panel are a type of birth defect. Birth defects are reportable under State Law, Official Code of Georgia Annotated (O.C.G.A.) 31-12-2, which mandate the reporting of notifiable diseases and Chapters 290-5-3-.02 and 290-5-24 of the Rules of Department of Community Health, which regulate the reporting of notifiable diseases and metabolic disorders. Cases of birth defects are reportable to the Division of Public Health through the Georgia Birth Defects Reporting and Information System (GBDRIS) within 7 days of the confirmatory diagnosis.
In addition, a child identified with a disorder on the Georgia newborn screening panel requires a referral to Children 1st.